MedTrace Logo

Effect of Meal Replacement Therapy on Glucose Control and Metabolic Parameters in Patients With Uncontrolled Diabetes

NCT06862180 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2025-03-06

No results posted yet for this study

Summary

To evaluate the effect of meal replacement therapy on glucose control and other metabolic parameters in patients with uncontrolled type 2 diabetes.

Methodology:

This is an open-label, prospective, randomized control trial study. Study duration. August 2023 - March 2026. Study location. This study will be conducted at the Klinik Rawatan Keluarga and diabetes clinic Hospital Universiti Sains Malaysia.

Source Reference :

People with type 2 diabetes mellitus attending the Hospital Universiti Sains Malaysia.

Study source population :

People with type 2 diabetes mellitus attended Klinik Rawatan Keluarga and diabetes clinic Hospital Universiti Sains Malaysia during the study period.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

OTHER

Meal replacement therapy

A serving of Contro Eazy Now is equivalent to 5 scoops (50g) contains 26.5g of carbohydrate, 10g of protein and 8.9g of fat. It supplies 215kcal of energy per serving

Sponsors & Collaborators

  • Ethos Healthcare Sdn Bhd company

    collaborator UNKNOWN

  • Hospital Universiti Sains Malaysia

    lead OTHER

Principal Investigators

  • Nani Draman, Masters · Professor

  • Siti suhaila, Masters · DR

  • NG Ying ying, Masters · DR

  • Najib Majdi, PHD · Prof

  • Khairun Nisah Ibrahim, Masters · Miss

  • Kanmani Kumaran, MD · DR

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-01
Primary Completion
2025-05-31
Completion
2026-03-31

Countries

  • Malaysia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06862180 on ClinicalTrials.gov